Purpose

This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥18 years of age - Positive family history of lung cancer (defined as): - Has ≥1 first-degree relative OR - Has ≥2 second-degree relatives with a diagnosis of non-small cell lung cancer or small cell lung cancer (NB: a first-degree relative = parent, sibling, or child, a second-degree relative = grandparent, blood-related aunt or uncle, grandchild, blood-related niece or nephew, half-sibling) - Willing to provide images from at least one previously obtained CT Chest scan, if available.

Exclusion Criteria

  • None

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Arm Groups

ArmDescriptionAssigned Intervention
Retrospective CT scan Participants will contribute images and corresponding radiology reports from at least one retrospective CT chest scan.
  • Diagnostic Test: CT scan
    Previously obtained computed tomography scan
  • Other: Sybil
    Image-based deep learning model

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114
Contact:
Allison Chang, MD
617-724-4000
aechang@mgb.org

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Allison Chang, MD
617-724-4000
aechang@mgb.org

Detailed Description

This is a non-therapeutic study that will enroll individuals who have a family history of lung cancer. During the study, participants will provide questionnaire responses regarding their personal medical history, family lung cancer history, and exposures along with contributing images from at least one previously obtained CT chest scan. The images and data collected will be analyzed by an image-based deep learning model (Sybil). Sybil is a type of artificial intelligence model that has been shown to accurately predict individuals' future risk of lung cancer based solely on images from a CT Chest scan, but it is unknown if it works well in people with a family history of lung cancer. It is expected that 2,250 will take part in this research study.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.